Teva Pharmaceutical Industries Ltd (TEVA)
16.26
+0.26
(+1.59%)
USD |
NYSE |
May 10, 16:00
16.28
+0.02
(+0.15%)
After-Hours: 20:00
Teva Pharmaceutical Industries Free Cash Flow: 878.00M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 878.00M |
December 31, 2023 | 842.00M |
September 30, 2023 | 608.00M |
June 30, 2023 | 1.173B |
March 31, 2023 | 964.00M |
December 31, 2022 | 1.042B |
September 30, 2022 | 514.00M |
June 30, 2022 | 476.00M |
March 31, 2022 | 585.00M |
December 31, 2021 | 236.00M |
September 30, 2021 | 88.00M |
June 30, 2021 | -131.00M |
March 31, 2021 | -94.00M |
December 31, 2020 | 638.00M |
September 30, 2020 | 902.00M |
June 30, 2020 | 894.00M |
March 31, 2020 | 413.00M |
December 31, 2019 | 223.00M |
September 30, 2019 | -42.00M |
June 30, 2019 | 84.00M |
March 31, 2019 | 449.00M |
December 31, 2018 | 1.795B |
September 30, 2018 | 2.233B |
June 30, 2018 | 2.534B |
March 31, 2018 | 2.75B |
Date | Value |
---|---|
December 31, 2017 | 1.351B |
September 30, 2017 | 516.00M |
June 30, 2017 | 1.173B |
March 31, 2017 | 1.719B |
December 31, 2016 | 2.989B |
September 30, 2016 | 4.599B |
June 30, 2016 | 4.282B |
March 31, 2016 | 4.805B |
December 31, 2015 | 4.77B |
September 30, 2015 | 4.855B |
June 30, 2015 | 5.144B |
March 31, 2015 | 4.694B |
December 31, 2014 | 4.198B |
September 30, 2014 | 3.248B |
June 30, 2014 | 2.252B |
March 31, 2014 | 2.041B |
December 31, 2013 | 2.206B |
September 30, 2013 | 2.954B |
June 30, 2013 | 3.537B |
March 31, 2013 | 3.824B |
December 31, 2012 | 3.468B |
September 30, 2012 | 3.329B |
June 30, 2012 | 2.736B |
March 31, 2012 | 2.897B |
December 31, 2011 | 3.081B |
Free Cash Flow Range, Past 5 Years
-131.00M
Minimum
Jun 2021
1.173B
Maximum
Jun 2023
514.65M
Average
549.50M
Median
Free Cash Flow Benchmarks
Viatris Inc | 2.325B |
Alvotech | -358.66M |
AstraZeneca PLC | 5.785B |
Corcept Therapeutics Inc | 124.84M |
GSK PLC | 6.584B |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -124.00M |
Cash from Investing (Quarterly) | 144.00M |
Cash from Financing (Quarterly) | -151.00M |
Free Cash Flow Per Share (Quarterly) | -0.2208 |
Free Cash Flow to Equity (Quarterly) | -59.00M |
Free Cash Flow to Firm (Quarterly) | -25.84M |
Free Cash Flow Yield | 4.80% |